USE OF TINROSTIM FOR CORRECTION OF IMMUNE CHANGES AT ONCO-GYNECOLOGY PATIENTS WITH SURGICAL COMPLICATIONS
Abstract
The materials proving expediency of use of biologically active additive «Tinrostim» at a stage of preoperative care and in case of development of postoperative complications at onco-gynecologic patients for prophylaxis and correction of immune system changes are shown. The most informative are determined immune markers of postoperative complications allowing monitoring the severity of complications (level of CD4 +-lymphocytes, phagocytes parameter and phagocytes number of neutrophils) and to estimate the efficiency tinrostim in treatment and prophylaxis.
About the Authors
T. S. ZaporozhetsRussian Federation
Vladivostok
T. L. Gritsyuk
Russian Federation
Vladivostok
N. N. Besednova
Russian Federation
Vladivostok
References
1. Берман В.М., Славская Е.М. // Журн. микробиол. – 1965. – № 3. – С. 8–13.
2. Дмитриева Н.В., Петухова И.Н. // РМЖ. – 2003. – Т. 11, № 18. – С. 15–19.
3. Земсков А.М., Караулов А.В., Земсков В.М. Комбинированная иммунокоррекция. – М. : Наука. – 1994.
4. Лихованцева, В.Г., Слепова О.С., Бровкина А.Ф. // Иммунология. – 2001. – № 2. – С. 25–26.
5. Тотолян А.А. // Иммунология. – 1999. – № 12. – С. 75–108.
6. Тугуз А.Р. Иммунопатогенез ранних послеоперационных осложнений у онкогинекологических больных : автореф. дисс. ... докт. мед. наук. – М., 2002.
7. Manchini G., Carbonara A.O., Heremans J.F. // Immunochemistry. – 1965. – Vol. 2, No. 3. – P. 235–254.
8. Nowak M., Szpakowsky V., Malinowski A. et al. Serum cytokines in patients with ovarian cysts // Ginecol. Pol. – 2001. – Vol. 72, No. 12A. – P.1444–1448.
Review
For citations:
Zaporozhets T.S., Gritsyuk T.L., Besednova N.N. USE OF TINROSTIM FOR CORRECTION OF IMMUNE CHANGES AT ONCO-GYNECOLOGY PATIENTS WITH SURGICAL COMPLICATIONS. Pacific Medical Journal. 2006;(4):71-73. (In Russ.)